Rating: Cautiously Bullish | Target Price: RMB 4.47-4.70 (base case, PB 0.95-1.00× Q3 2026 BPS of RMB 4.70) Current Price: RMB 4.33 (closing price on 2026-10-28) | Margin of Safety: ~3.2% (base-case fair value floor, calculated in this report) | Time Horizon: 12 months Total shares: 25.040 billion (A-shares 22.536 billion + H-shares 2.504 billion) | Total market cap: RMB 108.423 billion | PB(LF) 0.92× | PE(TTM) 12.56× (distorted denominator, for reference only)
Data as of 2026-10-28. On that day the company disclosed its Q3 2026 report (Q3 standalone net profit attributable to parent -62.21% YoY); the closing price used here predates the disclosure, and the market's repricing of the Q3 report is not yet complete — this is a timing limitation this judgment must explicitly acknowledge.
Shenwan Hongyuan is a Huijin-group, centrally owned A+H broker, a "second-tier leader" ranked 8th-9th in industry net profit. At the current price of RMB 4.33, PB is 0.92×, in its lowest range of the past decade and below book value; at a 9%-10% cost of equity, market pricing roughly implies "perpetual ROE of 8.3%-9.2% with zero growth" — largely consistent with the actual 9M26 annualized ROE of about 8.3%. That is, the market has paid neither for the ROE uplift following the higher trading volume center nor anything at all for the Huijin-group consolidation option. The price has already priced in earnings downgrades; it is reasonably cheap rather than deeply undervalued. The core fundamental tension lies in earnings: with proprietary trading contributing 56%-62% of revenue in a high-beta structure, Q3 2026 standalone net profit attributable to parent fell -62.21%, far off the industry's roughly -2% for the same quarter — pointing to idiosyncratic factors in a roughly RMB 311 billion non-equity proprietary book. The FY2026E base-case net profit attributable to parent is RMB 8.0-9.0 billion (about -16% to -5% YoY), and sell-side earnings downgrades over the next 1-2 quarters (current consensus implies an unachievable Q4 of +135%) pose a near-term headwind. Base-case fair value is RMB 4.47-4.70 (+3.2% to +8.5% vs. current); probability-weighted fair value across three scenarios at 30/50/20 is about RMB 4.64 (+7.2%); upside elasticity depends on stabilized trading activity (daily turnover holding above RMB 2 trillion) or Huijin-group consolidation involving the company (probability below 20% within 12 months), while downside is constrained by falling turnover and the 129% A/H premium pulling valuation. Cautiously bullish with a thin margin of safety — suited to staged left-side accumulation rather than momentum chasing.
Three caveats on methodology: first, the "lowest percentile in a decade" mechanically reflects BPS accretion from about RMB 3.7-4.0 in 2022-2023 to RMB 4.70 and the sector-wide re-rating of 2024-2025 — being below book does not by itself mean mispricing; second, "implied perpetual ROE of 8.3%-9.2%" is a model value backed out from a 9%-10% cost of equity, not a market quote, and is sensitive to COE assumptions; third, the closing price in this report predates the Q3 disclosure, so "pessimism priced in" has not yet been tested by the post-disclosure market. Overall judgment: pricing is reasonably cheap — the market has not paid for the higher ROE center or the consolidation option, but the discount is broadly commensurate with earnings downgrades; not deeply undervalued. If the daily turnover center stays at RMB 1.8-2 trillion and the ROE center holds at 7.5%-8%, PB recovery to 0.95-1.00× corresponds to RMB 4.47-4.70; conversely, if the market prices on through-cycle average ROE (2.9%-5.1% in 2022-2024), PB of 0.92× would actually be optimistic — which is precisely the bear-case pricing logic.
Two corrected statements: first, "negative growth is locked in" is too strong — the FY2026E range of RMB 8.0-9.0 billion implies a Q4 standalone profit of RMB 0.86-1.86 billion; if Q4 reverts to the 9M average of RMB 2.38 billion (requiring +69% QoQ, dependent on a trading-volume surge), the full year would be about RMB 9.5 billion, roughly flat YoY; negative growth is the base case, not a certainty. Second, the sample for "the only negative grower among five comparables" was incomplete (Galaxy and Huatai had not disclosed Q3 reports as of 10-28); what is demonstrable is "significant underperformance vs. disclosed peers and industry aggregates." It must also be noted: with the industry at roughly -2% in Q3 vs. the company at -62%, a deviation of about 60 percentage points points to idiosyncratic factors — the fixed-income positions and recognition timing within the roughly RMB 311 billion non-equity proprietary book (non-equity proprietary/net capital 329%) — rather than pure market beta; this means earnings recovery depends on both internal repositioning and a trading rebound, and elasticity may materialize more slowly than the sector's.
Triple constraints on the consolidation option: ① probability — no company-level announcements; mainstream speculation points to other targets; the probability of a deal involving the company within 12 months should be below 20%; ② re-rating effect — Guotai Haitong still trades below book at PB 0.84× post-merger (note this case was a Shanghai SASAC-system merger with bailout characteristics, limiting the analogy to top-down Huijin license consolidation, but it at least shows merger does not guarantee re-rating); ③ deal structure — with the A/H premium at about 129% (H-shares HKD 2.21 ≈ RMB 1.89), a share-swap deal would have H-share pricing constraining consideration flexibility for A-share holders. Personnel signals (CCB-system Huang Jianjun becoming General Manager in 2026-08) are worth tracking but alone do not justify raising the probability. This option is discounted in at a 20% bull-case probability; the base and bear cases contain no consolidation assumption.
Clarification on definitions: the trailing dividend yield of 3.70% spans fiscal years (FY2025 total RMB 2.754 billion + 2026 interim RMB 1.252 billion); strictly on calendar-2026 payments (FY2025 final RMB 1.878 billion + 2026 interim RMB 1.252 billion = RMB 3.130 billion), the yield is about 2.9%; on the forward basis of FY2026E attributable profit of RMB 8.0-9.0 billion × 29% payout, only about 2.1%-2.4%. Meanwhile, the 416.7% risk coverage ratio measures capital and liquidity adequacy, not the market-value stability of book net assets — the same Q3 report shows other comprehensive income of RMB 3.10 billion (fair value changes in other equity instrument investments) and deferred tax liabilities +803% (increase in taxable temporary differences, pointing to unrealized proprietary gains); BPS of RMB 4.70 itself contains market-sensitive unrealized gains, and the denominator will shrink in tandem in a bond or equity drawdown — the actual decline in a "PB 0.92→0.80" scenario would exceed pure multiple-compression estimates. The defensive value of below-book pricing is real but limited: it compresses downside in weak markets (asset value of RMB 4.70 exceeds the current price) but does not change the high-beta character.
FY2023/2024 revenue and net profit are on the retrospectively adjusted basis following the standardized warehouse-receipt accounting policy change (2025 annual report, Section 2, Note 2: per the MOF implementation Q&A of July 2025, FY2024 revenue was restated from RMB 24.735 billion to RMB 18.617 billion); all cross-period comparisons use adjusted figures. As a financial institution, the company is not suited to gross margin / free cash flow / net debt metrics; industry-standard metrics are shown.
| Metric | FY2023 | FY2024 | FY2025 | 2026Q1-3 (latest) |
|---|---|---|---|---|
| Operating revenue (RMB bn) | 17.309 | 18.617 | 24.256 | 17.859 |
| Net profit attributable to parent (RMB bn) | 4.606 | 5.211 | 9.507 | 7.141 |
| Adjusted (non-recurring excluded) net profit (RMB bn) | 4.386 | 5.072 | 9.432 | 7.046 |
| Weighted ROE (%) | 4.72 | 5.08 | 8.76 | 6.21 |
| Total assets (RMB bn, period-end) | 635.437 | 697.597 | 741.547 | 789.845 |
| Net assets attributable to parent (RMB bn, period-end) | 100.145 | 104.784 | 111.597 | 117.699 |
| Net operating cash flow (RMB bn) | 69.247 | 26.418 | 1.524 | 8.884 |
| Revenue mix: proprietary trading % of revenue | ~55.2 | ~59.7 | 61.57 | 56.64 (H1 basis) |
| Revenue mix: brokerage net fee income (RMB bn) | 4.59 | 4.603 | 5.993 | 3.779 (H1) |
| Leverage (total assets / net assets attributable, ×) | 6.35 | 6.66 | 6.64 | 6.71 |
Reasons for metric changes (company explanations attached for items with YoY ≥ ±20%): FY2025 revenue +30.29% — dual drivers of proprietary trading (investment income + fair value +34.31%) and brokerage (+30.20%), against 2025's Shanghai-Shenzhen turnover first exceeding RMB 400 trillion and margin balance +36.26% (2025 annual report MD&A); FY2025 attributable profit +82.46% — revenue +30.29% while business and administrative expenses rose only +0.83%, cost-to-income ratio falling from 56.80% to 43.95%, concentrated release of operating leverage (annual report MD&A expense section); 2026Q1-3 revenue -8.41%, attributable profit -10.92% — Q3 standalone revenue -48.45%, attributable profit -62.21%; the company did not attribute the single-quarter decline separately (prior-year Q3 of RMB 7.804 billion was the year's high base); on a cumulative basis it explained only net interest income +114.93% (higher margin financing and client deposit interest) and FX losses of RMB 0.121 billion (Q3 report item-by-item notes); operating cash flow plunged 94% in 2025 and turned negative in 2026H1 — explained respectively by "net cash outflow of RMB 24.469 billion from repo businesses" (2025 annual report) and "increases in financial instruments held for trading and in funds lent, a normal industry phenomenon" (2026 H1 results briefing), turning positive at RMB 8.884 billion for 9M.
9M revenue RMB 17.859 billion (-8.41%), attributable profit RMB 7.141 billion (-10.92%), adjusted profit RMB 7.046 billion (-11.35%), weighted ROE 6.21% (-1.20pp). The key is the single quarter: Q3 revenue RMB 4.023 billion, -49% QoQ; attributable profit RMB 1.410 billion, -62.21% YoY, -58% QoQ — the weakest quarter since 2024. Vs. the industry: 42 listed brokers' combined 9M attributable profit up roughly +30% (Guotai Haitong non-bank preview), CITIC +32.7% for 9M, while the company fell -10.92%, a significant miss; industry Q3 roughly -2% vs. the company -62% — a deviation far beyond what market beta can explain, pointing to unrealized losses or recognition timing in the roughly RMB 311 billion non-equity proprietary book (non-equity proprietary/net capital 329.02%) amid Q3 bond-market volatility, plus the high base of prior-year Q3 bull-market gains. The company provided no attribution for the single-quarter decline — the main flaw in this quarter's disclosure quality. On the balance sheet: total assets RMB 789.8 billion (+6.5% vs. prior year-end, down from the H1 peak of RMB 825.3 billion), net assets attributable to parent RMB 117.7 billion; deferred tax liabilities +803% to RMB 0.562 billion (increase in taxable temporary differences, pointing to accumulated proprietary unrealized gains), alongside other comprehensive income of +RMB 3.10 billion (fair value changes in other equity instruments) — unrealized gains on the balance sheet coexisting with single-quarter profit contraction, reflecting timing differences across financial asset accounts. On "beat or miss": the comparable sell-side consensus sample is only 2 estimates, formed around the Q3 disclosure (implying a full year of about RMB 10.65 billion, i.e., a Q4 standalone of about RMB 3.5 billion, +135% YoY — unachievable); the actual RMB 7.141 billion is negative relative to the lagged expectation, but the downgrades of the expectation itself are not yet complete — sell-side earnings downgrades over the next 1-2 quarters are an unavoidable near-term headwind for this stock.
Business model in brief: A two-tier structure of an investment holding group + a full-license securities firm. Revenue chain = light-capital intermediary businesses (brokerage 24.7%-27.3%, investment banking 5.0%, asset management 3.0%) + heavy-capital businesses (proprietary investment income and fair value changes 56%-62%, net interest income from margin financing roughly 2.7%-4.9%). This is not a subscription or recurring-revenue business — more than 80% of revenue is linearly tied to equity/bond market conditions and trading volume. The +30% revenue in the 2025 bull market and the -48% in a single quarter of 2026Q3 are two sides of the same coin.
Market-sensitivity test of earnings (replacing the cash-content test used for industrial companies; brokerage OCF contains client funds and repo fluctuations and naturally diverges from net profit — the swing in OCF/attributable net profit from 15.0x in FY2023 → 0.16x in FY2025 → -1.73x in 2026H1 mainly reflects client fund movements rather than deteriorating earnings quality): ① Directional proprietary exposure — proprietary equity securities and derivatives/net capital rose from 29.2% at end-FY2024 to 43.9% at end-FY2025 and 40.4% at end-2026Q3, alongside non-equity/net capital at 329% (roughly RMB 311.0 billion of bond positions); the company's FY2025 proprietary VaR (1-day, 95%) was RMB 316 million. FICC management commentary emphasizes "quant-neutral, client-flow transformation," but the rising equity share and the actual -62% swing in Q3 alone show the transformation is incomplete. ② Effective brokerage fee rate — brokerage net revenue +51.9% in 2026H1 vs. +96.9% for total market turnover, implying a fee rate of roughly -23%, in line with the industry commission decline but lagging top peers. ③ ROE decomposition: FY2025 weighted ROE of 8.76% ≈ net margin 39.2% × leverage 6.64x — a low-turnover combination. ROE elasticity comes from net margin (market beta), not from adding leverage (leverage stable at 6.64→6.71), meaning ROE falls quickly with net margin in weak markets (2022: 2.93%, 2023: 4.72%, 2024: 5.08% trace that path). ④ Revenue quality red flags: the company has long failed to disclose brokerage market share (asked directly at the earnings briefing, no figure was given); the surge in deferred tax liabilities suggests book profit includes unrealized gains.
Capital returns and shareholder returns: The ROIC/maintenance-capex framework does not apply to brokerages. From the shareholder-return perspective: FY2025 dividends of RMB 2.754 billion (+74.6%), payout ratio roughly 29%, with "multiple dividends per year" institutionalized (2025 interim RMB 876 million + final RMB 1.878 billion; 2026 interim RMB 1.252 billion already announced); no equity refinancing since the 2019 H-share listing, total share capital stable at 25.040 billion shares, no dilution. Conclusion: dependence of book profit on market conditions is the essence of this business, not a flaw; at ROE around 8% and a 29% payout ratio, the true shareholder return is roughly 2.3%-2.9%/year (forward basis). Buying below book value is essentially "buying a market-direction option plus a dividend stream at below-book price."
Words-vs-deeds consistency: pragmatic type, no verifiable quantitative commitments. The company has no guidance convention; the 2025 annual report offers only qualitative outlook for investment banking/wealth/FICC for 2026. Verifiable commitments lie in shareholder returns — the "multiple dividends per year" pledge has been consistently honored (FY2025 total RMB 2.754 billion, +74.6% YoY; the 2025 annual report's claim that "cash dividends hit a ten-year high" matches the data; the 2026 interim plan of RMB 1.252 billion is proceeding on schedule). Earnings briefing communication quality is high: quantitative responses were given to sensitive questions such as negative OCF and Q2 fair-value changes of RMB 4.822 billion; but when asked about total proprietary scale and brokerage/margin market share, no specific figures were given, with answers limited to risk-control metric constraints (2026-08-31 earnings briefing minutes; 2026-09-15 IR record) — transparency above average, avoidance of the most sensitive market-share data.
Shareholder friendliness: friendly, leaning neutral. The ~29% payout ratio is mid-range among top brokerages, with the edge coming from a stable mechanism (twice a year) and an upward direction; no buyback plan; no equity refinancing dilution since 2019. Based on FY2026E earnings and the current price, forward dividend yield is 2.1%-2.4%; dividend attributes weaker than classic high-yield brokerages.
Risk signals: ① President Huang Hao resigned from all positions on 2026-08-14 "due to work arrangement reasons" (announcement confirms no disagreement with the board); Huang Jianjun, president of major shareholder CCB Investment, took over the same day, with legal representative change completed in September — interpretation of the shareholder's preemptive personnel placement is covered in C3; a smooth transition, but strategic continuity remains to be observed; ② against the backdrop of 7 brokerage presidents voluntarily resigning in 2026, the executive change is not an isolated event; ③ no record of controlling-shareholder selling, overall pledge ratio only 0.31% (per the 2026-10-28 shareholder register), clean ownership structure; ④ normal rotation of independent director candidates (2026-09-24 announcement). Overall: no major governance flaws; the president change is the primary window for observing strategic continuity over the next 12 months.
| Segment | Revenue Share | Operating Margin | Revenue YoY | Business Logic in One Line |
|---|---|---|---|---|
| Institutional Services & Trading (proprietary/market-making/derivatives/research) | 43.2% (39.1% in 2026H1) | 68.86% (+6.76pp) | +43.42% (H1 +5.33%) | Heavy-capital client-flow + proprietary mix, highest margin |
| Personal Finance (brokerage/margin financing/product sales) | 38.8% (H1 40.8%) | 45.38% (+16.05pp) | +19.69% (H1 +35.79%) | Intermediary + capital intermediation, elastic to turnover and margin balances |
| Corporate Finance (investment banking + principal investment) | 12.9% (H1 15.5%) | 39.95% (+26.26pp) | +30.02% (H1: IB -11.59%, principal investment +50.31%) | IPO underwriting ranked 4th in industry (2026H1) |
| Investment Management (asset management/public funds/private funds) | 5.1% (H1 4.6%) | 25.38% (+4.05pp) | +18.85% (H1 +4.39%) | AUM RMB 178.1 billion + stake in Fullgoal Fund, pressured by fee cuts |
The profit engine segment is Institutional Services & Trading: 43.2% of revenue, 68.86% operating margin, contributing roughly 60% of group operating profit by "revenue share × margin" — it was both the main engine of 2025's +43% growth and the epicenter of the halved Q3 2026 quarterly profit; the segment structure determines how deeply results are tied to proprietary investment. Margin spread of 43.5 percentage points (68.86% vs 25.38%): institutional trading earns capital spreads and risk premia, personal finance earns intermediation fees, and investment management is squeezed by public-fund fee cuts — three businesses with completely different pricing power and capital intensity; consolidated "revenue growth" must be decomposed. Marginal changes: 2026H1 investment banking revenue -11.59% (fee reform + pacing effects), principal investment +50.31%; corporate finance mix tilting toward investment income.
Accounting red flags (all low-grade; no evidence of malicious manipulation, but they affect readings):
Cross-period consistency:
Conclusion: no obvious manipulative accounting techniques found in the financials examined; all three red flags are basis/timing issues; the deferred-tax unrealized gains and the RMB 3.1 billion OCI item both point to BPS's market sensitivity, already factored into C4.
Current market data (close of 2026-10-28): price RMB 4.33, total market cap RMB 108.423 billion (25.040 billion shares); PB(LF) 0.92x (BPS RMB 4.70, end-2026Q3) — per our own calculation, at its lowest tier over 1/3/5/10 years; the mechanical nature of the percentile should be noted (BPS accretion + sector re-rating shifting the historical range rightward); PE(TTM) 12.56x (TTM attributable profit RMB 8.632 billion = 95.07 − 80.16 + 71.41); earnings are in a downswing so the denominator is distorted — this multiple is for reference only, not a cheap/expensive signal; the "low" of peers' PE(TTM) at 7.5-10.2x and Shenwan's "high" are both denominator effects. Dividend yield: trailing 3.70% (cross-fiscal-year cumulative basis), roughly 2.9% on a 2026 calendar-year basis, roughly 2.1%-2.4% forward.
Peer comparison (PB at 2026-10-28 close; ROE from each firm's latest disclosed period):
| Company | PB (x) | ROE (latest) | Net Profit Growth (latest) | Notes |
|---|---|---|---|---|
| CITIC Securities | 1.22 | 9.03% (2026Q1-3) | +32.7% (Q1-3) | Absolute leader, highest PB premium in the sector |
| China Galaxy Securities | 1.04 | 5.14% (2026H1; FY2025 8.69%) | +20.2% (H1) | Most direct comparable: both Huijin-affiliated, similar retail focus |
| GF Securities | 1.02 | 7.00% (2026H1) | +80.1% (H1) | Excess profits from public-fund asset management |
| Huatai Securities | 0.87 | 5.53% (2026H1) | +54.9% (H1) | Wealth management benchmark, low PB high growth |
| Guotai Haitong | 0.84 | 5.76% (2026H1, incl. merger effects) | +28.7% (H1) | Largest capital post-merger yet below book |
| Shenwan Hongyuan | 0.92 | 6.21% (2026Q1-3; FY2025 8.76%) | -10.9% (Q1-3) | Only top-tier name with negative growth |
Market-implied expectations: backing out with a 9%-10% cost of equity, PB 0.92x implies "perpetual ROE of 8.3%-9.2% with zero growth" — consistent with 9M26 annualized ROE of roughly 8.3%. In one sentence: the current price requires the company to sustain its 2025-2026 active-market profitability in perpetuity, while reality is a strong cyclical swing between 8%-8.8% in active markets and 3%-5% in weak ones; the market is neither paying for an upward ROE re-rating nor for the consolidation option, but is also not excessively punishing the weak-market scenario. "Reasonably cheap" means the expectation gap is shallow; odds depend on events.
Three layers of value (EPV): Asset value RMB 4.70/share (BPS; net capital of RMB 94.53 billion and risk coverage ratio of 416.7% support book credibility; includes market-sensitive unrealized gains); zero-growth EPV roughly RMB 3.68/share (normalized ROE 7.5% × BPS 4.70 = RMB 0.35/share sustainable earnings, divided by 9.5% cost of equity on an equity basis; normalization basis: 2023-2024 weak-market 4.7%-5.1% treated as the cyclical trough, 2025-2026 bull-market peak not extrapolated, taking the active-market midpoint of 7.5%); the current price of RMB 4.33 sits in a sandwich of "asset value 4.70 > current price 4.33 > EPV 3.68" — growth options (consolidation + trading volume expansion) account for roughly 14.9% of the current price (our calculation); the market applies an 8% discount to book assets overall. Note: a 14% growth-option share is not trivial — the claim that "the market pays only for zero growth" does not hold; the correct reading is that the market prices "assets + current profitability" at close to full but slightly discounted, with elasticity concentrated in the unpriced event layer.
Three scenarios and odds (12 months; fair value range = PB × BPS of RMB 4.70):
| Scenario | Probability | Fair Range | vs Current Price | Key Swing Factors |
|---|---|---|---|---|
| Bear | 30% | RMB 3.76-4.23 (PB 0.80-0.90) | -13%~-2% | Average daily turnover falls to RMB 1.2-1.5 trillion or margin balance drops below RMB 2.3 trillion, proprietary shrinks further, ROE falls back to 5.5%-6.5%; PB floor anchor = own weak-market lows and below-book peer group (Guotai Haitong 0.84 / Huatai 0.87) |
| Base | 50% | RMB 4.47-4.70 (PB 0.95-1.00) | +3.2%~+8.5% | Average daily turnover at RMB 1.8-2 trillion midpoint; FY2026 attributable profit RMB 8.0-9.0 billion, FY2027 recovery to RMB 8.8-9.8 billion; PB anchor = Galaxy PB/ROE mapping of roughly 0.96x (independent of current price), no reliance on consolidation assumptions |
| Bull | 20% | RMB 5.41-6.11 (PB 1.15-1.30) | +25%~+41% | Huijin-affiliated consolidation involving the company (share swap/transfer) or turnover back above RMB 2.5 trillion, ROE reaching 9%-10%; PB anchor = CITIC's current 1.22 and own 3-year high of 1.55, conservatively bracketed |
Probability-weighted fair value roughly RMB 4.64 (+7.2%).
Right-skewed distribution but modest midpoint: the PB 1.00x anchor at the top of the base-case range is based on "same-ROE-tier peer (Galaxy 1.04) × discount for our own earnings downgrade," independent of the current price; we do not adopt a "merger必然 re-rating" narrative, hence the 20% bull-case probability is below the event's imaginative space. External benchmark check: no particularly bearish sell-side view available for the current period (no new note since the Q3 disclosure); the most recent bearish pricing on record is CITIC Securities on 2023-04-07 (1.0x PB, target RMB 4.02, Hold, during the prior deep earnings downturn) — broadly consistent with our bear range (our bear floor is lower, as current BPS includes unrealized gains and bond exposure is larger); the external bullish benchmark is CICC on 2026-05-02 (target RMB 6.8, 1.4x 2026E ex-perpetual PB), formed after Q1 results and before digesting the Q3 decline; as a reference beyond the bull-case upper bound, it should be discounted.
Our earnings forecast vs. third parties:
| Basis | FY2026E Attributable | FY2027E Attributable |
|---|---|---|
| This report | RMB 8.0-9.0 billion (midpoint 8.5, roughly -16%~-5% YoY) | RMB 8.8-9.8 billion (+8%~+13%) |
| Sell-side consensus (n=2, lagged) | roughly RMB 10.65 billion (+12%) | roughly RMB 11.2 billion (EPS 0.45, n=1) |
| Management guidance | No quantitative guidance (company convention) | No quantitative guidance |
This report is roughly 15%-25% below consensus; the core divergence is the Q4 assumption (our RMB 0.86-1.86 billion vs. consensus-implied RMB 3.5 billion); FY2027 recovery assumptions = turnover midpoint sustained at RMB 1.8-2 trillion + low proprietary base + high net interest income growth (Q1-3 +114.93%).
Conclusion: reasonably cheap; target price RMB 4.47-4.70, margin of safety roughly 3.2% (thin). Assess quality and price separately: quality — a top second-tier Huijin-affiliated firm with distinctive research and institutional businesses, but ROE midpoint of 7.5%-8.5% below CITIC/GF, and a major underperformance vs. the industry in 2026; price — the lowest PB percentile in ten years + below-book + 2.1%-2.9% forward dividend yield already price in pessimism; the same asset is roughly 56% cheaper in H-shares (A/H premium 129%, which also acts as a ceiling pulling on any A-share re-rating). Illiquidity caveat does not apply (A-share average daily turnover roughly 0.2%-0.5% of free-float market cap).
1. Industry Space: In FY2025, the industry's 150 securities firms (SAC caliber, unaudited) posted total operating revenue of RMB 541.171 billion and net profit of RMB 219.439 billion, both multi-year highs since 2016; total assets stood at RMB 14.83 trillion, net assets at RMB 3.34 trillion, and net capital at RMB 2.44 trillion at end-2025 (China Securities Association, published 2026-03-26). Growth trajectory: revenue RMB 395.0 billion in 2022 (-21%) → RMB 438.0 billion in 2024 (+8.0%) → RMB 541.171 billion in 2025 (+19.95%); net profit RMB 143.3 billion in 2022 → RMB 219.439 billion in 2025 (+31.2%), with industry annualized ROE of 6.78% in 2025 (BOC International Securities summary). In 2026, the high-growth cycle continues but cools quarter by quarter: H1 net profit attributable to shareholders of the 43 listed brokers was RMB 154.682 billion, up 49.1% YoY (Association, 2026-09-01), with growth decelerating from Q3 (CITIC +32.7% for the first three quarters, SWS -10.9%). Volume engine: average daily A-share stock-plus-fund turnover in the first three quarters of 2026 was RMB 3.06 trillion (+59% YoY, Wind/Soochow caliber), but Q3 single-quarter daily average of RMB 2.32 trillion was down 20.5% QoQ; margin financing balance first broke RMB 3 trillion on 2026-06-23, then fell back to about RMB 2.49 trillion by October (-16.6% from peak, Securities Star caliber, 2026-10-15). Price engine stalling: industry net commission rate fell to 0.0171% and split-commission rate to 0.0357% (vs. 0.07%-0.08% before fee reform), both record lows—industry growth relies entirely on "volume," while fees are a long-term drag. No authoritative institution provides a single CAGR for the next 3-5 years; the industry's headroom depends on the rising share of direct financing, household wealth reallocation, and concentration gains under the "first-tier investment banks" policy.
2. Value Chain and Value Distribution: Securities firms sit in the middle of the capital-markets intermediary chain—upstream funding side (trading and settlement funds of 240 million A-share investors; industry-wide client margin of RMB 3.24 trillion in 2026H1; institutional funds from mutual funds/insurers) and asset side (IPO/refinancing/bond issuers), downstream to investors and real-economy financing parties. Key divergence in value distribution: profit pools are concentrating in capital-heavy segments (prop trading/market making/margin financing) and among leading players—in 2025, prop trading accounted for 40.9% of listed brokers' revenue and brokerage 27.7%, together nearly 70%; investment banking revenue CR5 is about 50%-56%. The Company holds a full-license integrated broker position, with 2025 revenue at about 4.5% and net profit about 4.3% of the industry: its pricing power over issuers is weaker than the "Big Three plus CICC" (2026H1 investment banking revenue -12%); bargaining power over retail clients remains suppressed by internet platforms and fee cuts; value accrues in prop trading/capital-heavy segments—meaning the Company's industry standing and earnings volatility share the same source. The differentiated lever on the capital-light side is the SWS Research Institute: 2025 mutual fund split commissions of RMB 404 million (+37.4%), industry rank rising from 13th to 8th; 2026H1 split commissions exceeded RMB 300 million, +121.25% YoY (top tier in growth, China.com Finance, 2026-09-02).
3. Supply-Demand and Competitive Landscape: Demand is driven by market activity and policy (IPO pace, "Six M&A Measures"); supply consists of 150 licensed brokers (licenses essentially frozen), with competitive supply determined by capital—leaders are expanding balance sheets rapidly (Guotai Haitong total assets RMB 2.11 trillion, CITIC around the RMB 1.7 trillion level, SWS Research first surpassing RMB 800 billion in 2026H1). Concentration: industry revenue CR5/CR10 = 37.9%/57.6%, net profit CR10 = 63.5% (2025, Soochow Securities/Wind caliber), steadily rising vs. 2019; ROE median 9.89% for leaders (top 15 by net assets) vs. 5.01% for the tail (bottom 15). Entry barriers: license freeze, net capital thresholds, and tiered qualifications such as primary dealer status for OTC derivatives (held only by leaders). Competitive intensity: homogenization remains fierce—commission rate price wars, margin rate competition, and mutual fund fee reform shrinking the research commission pool (2024 split commissions -35%); the leading brokerage market share changed hands for the first time (Guotai Haitong RMB 15.138 billion surpassing CITIC's RMB 14.753 billion), and the top ten brokers' share of commission brokerage rose to 68% in 2026H1 (Times Finance, 2026-10-28); Guotai Haitong, GF, Huatai, and Guosen are growing faster than the industry, with the Company squeezed on both retail and split commissions. Substitution threats: Eastmoney/Tonghuashun diverting retail brokerage and margin business; bank wealth management products/mutual funds diverting wealth-management flows.
4. Cyclicality and Regulation: The cycle is in a "high-level digestion, direction TBD" phase—market rally launched in 2024-09 → broad recovery in 2025 (9-year highs) → overheated 2026H1 (margin balance RMB 3 trillion, 43 brokers' net profit +49%) → Q3 turnover -20.5% QoQ, margin balance declining, sector pullback YTD (Galaxy/Huatai down over 20%). Leading indicators: daily average turnover (an RMB 1.5-2 trillion center in October is the warning zone), direction of margin balance, new account openings, IPO/refinancing pace, and sector PB percentile. Regulatory direction is neutral-to-positive: ① "First-tier investment bank building" (2024 CSRC blueprint plus streamlined M&A approvals, with Guotai Haitong as the template; Wu Qing reiterated support for consolidation at the Financial Street Forum on 2026-10-19); ② "One participation, one control" rule (Central Huijin simultaneously holding/sharing stakes in SWS Research, Galaxy, CICC, CSC, etc.)—both a source of consolidation optionality and an institutional constraint (requiring exemptions or prior equity transfers); ③ the three phases of mutual fund fee reform fully implemented by 2026-01 (cumulative concessions of about RMB 50 billion), continuing to compress capital-light fees; ④ the risk-metrics framework and consolidated supervision cap balance sheet expansion. Net effect on the Company: rising concentration is favorable, but fee reform and commission wars directly compress its brokerage/research monetization; consolidation benefit is an option, not an entitlement.
5. Peer Benchmarking (see Chapter 10 valuation table; operating metrics supplemented here): Size ranking—2025 net profit attributable to shareholders: CITIC RMB 30.076 billion, Guotai Haitong RMB 27.809 billion, Huatai RMB 16.383 billion, GF RMB 13.702 billion, Galaxy RMB 12.520 billion, SWS Research RMB 9.507 billion (6th-8th tier; subsidiary Shenwan Hongyuan Securities at RMB 10.363 billion ranked 8th industry-wide); total assets: Guotai Haitong RMB 2.11 trillion > CITIC ~RMB 1.7 trillion > Galaxy RMB 1.06 trillion > SWS RMB 825.3 billion (2026H1)—the gap with Galaxy (also Central Huijin-affiliated) is widening (balance-sheet expansion pace), and the gap with the "Big Two" is roughly 2-3x. 2026 divergence: SWS is the only player in the leading group with negative profit growth (-10.9% vs. peers +20% to +80%). Core differences: CITIC has no weak spots across businesses; Guotai Haitong enjoys merger synergies plus the largest capital base; Huatai leads in digital retail; GF has a mutual fund asset-management profit pool; Galaxy, also Huijin-affiliated, is a retail powerhouse expanding faster; SWS Research differentiates via its research institute brand, institutional prime brokerage, and FICC client base—but the revenue scale of these differentiated businesses (split commissions in the RMB 400 million range) is not yet sufficient to hedge prop trading volatility.
6. Company's Industry Positioning: Second-tier leader, a chaser. Central Huijin SOE credit (Jianyin plus Huijin direct holdings of 46.39%, ~52.9% voting rights in the broader system) and low funding costs are structural advantages; the research business is a capital-light brand asset; market share trended up in 2025 (net profit growth +82.5%, outpacing the industry's +31.2%) but fell back in 2026 (-10.9% vs. industry H1 +49%). A+H dual listing (H shares 06806.HK, listed 2019-04, 2.504 billion shares): A shares at RMB 4.33 vs. H shares at HK$2.21 (≈RMB 1.89), A/H premium of about 128.8% (closing 2026-10-28; reference rate HK$100 = RMB 85.63, 2026-10-27), on the high side among A+H brokers—H-share discount mainly reflects thin liquidity (only 47 registered H-share holders) and foreign investors' declining risk appetite for Chinese brokers; YTD H shares -29.4% vs. A shares -18.2%, widening the premium. Market share caliber note: the Company's claim of "industry-leading/top tier" is qualitative; its 8th-9th industry rank in net profit is supported by Association and third-party data, and the two calibers do not materially conflict. However, the Company has long not disclosed brokerage market share; this report infers share dilution indirectly via the scissors gap between "brokerage revenue growth vs. market turnover growth"; precise share data unavailable.
The decisive factor for brokers is not the single-store model or order book, but the elasticity coefficients of the revenue chain to market variables. Decomposing the Company's revenue chain (FY2025 caliber): prop trading (investment income + fair value, 61.6%)—simultaneously tied to equity index direction and bond yields (~RMB 311 billion non-equity exposure; non-equity prop/net capital at 329%); brokerage (24.7%)—tied to daily turnover × commission rate (both declining); margin interest (net revenue share 2.7%-4.9%; margin balance RMB 93.8 billion, 3.69% market share)—tied to margin balance × spread; investment banking (5.0%) and asset management (3.0%)—tied to regulatory pace and fee rates. A verified sample of three-line resonance: 2025 turnover +36%/equity bull market → revenue +30%, net profit +82% (operating leverage amplification); 2026Q3 turnover -20.5% QoQ plus bond market volatility → single-quarter net profit -62% (same amplification). A key correction to intuition: the Company's Q3 decline of -62% far exceeded the industry's roughly -2%—the Company's elasticity coefficient to markets is above the industry average (dual equity + bond exposure; institutional trading segment at 43% of revenue), implying that if activity recovers, its rebound elasticity would also be superior, though timing depends on prop book repositioning. The long decline in commission rates (0.031% → 0.027% → industry net rate 0.0171%) is a structural negative independent of the cycle: even if turnover holds, brokerage revenue erodes at roughly 10% annual fee deflation—"compensating price with volume" holds only when volume growth exceeds 15%; with industry turnover +97% in 2026H1, the Company's brokerage grew only +52%, with the volume dividend nearly halved by fees and share loss.
Overall verdict: cautiously bullish, confidence 0.55, 12-month horizon. Pillars of the call: on price, PB of 0.92x below book, lowest-decile range in ten years, forward dividend yield 2.1%-2.9%—pessimism is priced in (C1/C4); on odds, base case +3.2% to +8.5%, weighted +7.2%, right-skewed distribution (synthesis of C1-C3). Constraints on the call: earnings downgrades incomplete (C2), upside elasticity depends on two events outside the Company's control (trading stabilization or consolidation completion, C3), the 129% A/H premium caps recovery, and BPS includes unrealized gains so "below book but not below floor" does not necessarily hold in weak markets (C4). Confidence is set at 0.55 because directional realization requires market variables to cooperate, and the divergence between this call and the current price (about +7%) sits in a historically neutral hit-rate zone—we lack an evidence chain stronger than the baseline proving the market wrong; the gain comes from "pessimistic pricing + event options" rather than "significant market mispricing." Strategic implication: suited to staged left-side accumulation (thin margin exists below the base-case fair value floor of RMB 4.47), not suited to trend chasing; before catalysts are realized (consolidation/volume surge), returns come mainly from dividends and valuation reversion.
Key Risks and Monitoring Points:
Data sources: Company periodic reports and announcements (cninfo), China Securities Association, industry research from Wind/Soochow Securities/BOC International Securities, and public reporting from 21st Century Business Herald/Cailianshe/National Business Daily/China.com Finance, detailed in the thesis key-citations list. This report does not constitute investment advice.